Article info
PDFInterstitial lung disease
Original article
Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume
- Correspondence to Dr Martin Kolb, Department of Medicine and Pathology/Molecular Medicine, McMaster University, 50 Charlton Ave. E., Hamilton, ON L8N 4A6 Canada; kolbm{at}mcmaster.ca
Citation
Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume
Publication history
- Received March 30, 2016
- Revised August 23, 2016
- Accepted August 27, 2016
- First published September 26, 2016.
Online issue publication
March 17, 2017
Article Versions
- Previous version (26 September 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/